This is the definitive test of whether GLP-1s can slow cognitive decline in early Alzheimer's, as the trials are large enough with long enough follow-up time to tell real treatment effect from noise that has really clouded smaller, shorter studies
Thus, its our mission and responsibility to design and manufacture products using the highest-quality, effective, clinically tested, and nature-based active ingredients
Has It Happened Before
Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hanselmann A, et al
Tirzepatide wins for side-effect profile, mature community data, and ease of titrationthanks to more predictable GI side effects and a longer track record at physique-focused dosing